12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

  • Nuwellis NUWE stock rose 13.9% to $0.28 during Thursday's after-market session. The company's market cap stands at $8.9 million.
  • Marker Therapeutics MRKR stock moved upwards by 13.45% to $0.48. The company's market cap stands at $40.1 million.
  • Eloxx Pharmaceuticals ELOX stock rose 9.8% to $0.15. The market value of their outstanding shares is at $12.9 million.
  • Magenta Therapeutics MGTA stock rose 9.32% to $1.29. The company's market cap stands at $75.9 million.
  • Alterity Therapeutics ATHE shares moved upwards by 8.46% to $0.47. The company's market cap stands at $18.7 million.
  • GlycoMimetics GLYC shares increased by 7.58% to $0.62. The market value of their outstanding shares is at $32.7 million.

Losers

  • Immunic IMUX stock declined by 76.2% to $2.19 during Thursday's after-market session. Trading volume for this security closed at 6.6 million, accounting for 296.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $66.9 million.
  • Sientra SIEN stock fell 16.25% to $0.33. Today's trading volume for this security ended up closing at 1.2 million shares, which is 156.0 percent of its average volume over the last 100 days. The company's market cap stands at $21.7 million.
  • Tenet Healthcare THC stock fell 14.4% to $46.5. Trading volume for this security closed at 378.8K, accounting for 32.0% of its average full-day volume over the last 100 days. The company's market cap stands at $5.0 billion. The company's, Q3 earnings came out today.
  • Pulse Biosciences PLSE shares fell 11.22% to $1.9. The company's market cap stands at $70.5 million.
  • Summit Therapeutics SMMT stock fell 7.5% to $1.11. The company's market cap stands at $223.3 million.
  • Creative Medical Tech CELZ stock fell 7.37% to $0.39. The company's market cap stands at $5.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-TFMMovers